These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24751104)

  • 21. Substance P receptor expression in human skin keratinocytes and fibroblasts.
    Liu JY; Hu JH; Zhu QG; Li FQ; Sun HJ
    Br J Dermatol; 2006 Oct; 155(4):657-62. PubMed ID: 16965412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of Neurokinin-1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs.
    Grobman M; Reinero C
    J Vet Intern Med; 2016 May; 30(3):847-52. PubMed ID: 26995558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of NK-1 receptor mRNA in murine T lymphocytes.
    McCormack RJ; Hart RP; Ganea D
    Neuroimmunomodulation; 1996; 3(1):35-46. PubMed ID: 8892359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
    Ge C; Huang H; Huang F; Yang T; Zhang T; Wu H; Zhou H; Chen Q; Shi Y; Sun Y; Liu L; Wang X; Pearson RB; Cao Y; Kang J; Fu C
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19635-19645. PubMed ID: 31488714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
    Li X; Ma G; Ma Q; Li W; Liu J; Han L; Duan W; Xu Q; Liu H; Wang Z; Sun Q; Wang F; Wu E
    Mol Cancer Res; 2013 Mar; 11(3):294-302. PubMed ID: 23345604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of NK-1 Receptor Antagonist (Maropitant) to Morphine as a Pre-Anaesthetic Agent for Canine Ovariohysterectomy.
    Marquez M; Boscan P; Weir H; Vogel P; Twedt DC
    PLoS One; 2015; 10(10):e0140734. PubMed ID: 26513745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs.
    Alvillar BM; Boscan P; Mama KR; Ferreira TH; Congdon J; Twedt DC
    Vet Anaesth Analg; 2012 Mar; 39(2):201-5. PubMed ID: 22103569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of substance P and the NK-1 receptor in cancer progression.
    Muñoz M; Coveñas R
    Peptides; 2013 Oct; 48():1-9. PubMed ID: 23933301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
    Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
    Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the research and application of neurokinin-1 receptor antagonists.
    Hong X; Ma J; Zheng S; Zhao G; Fu C
    J Zhejiang Univ Sci B; 2024 Feb; 25(2):91-105. PubMed ID: 38303494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the role of substance P in the growth of brain tumors.
    Harford-Wright E; Lewis KM; Vink R; Ghabriel MN
    Neuroscience; 2014 Mar; 261():85-94. PubMed ID: 24374326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma.
    Muñoz MF; Argüelles S; Rosso M; Medina R; Coveñas R; Ayala A; Muñoz M
    Biomed Res Int; 2022; 2022():6291504. PubMed ID: 35434136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer.
    Friess H; Zhu Z; Liard V; Shi X; Shrikhande SV; Wang L; Lieb K; Korc M; Palma C; Zimmermann A; Reubi JC; Büchler MW
    Lab Invest; 2003 May; 83(5):731-42. PubMed ID: 12746482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.
    Gillespie E; Leeman SE; Watts LA; Coukos JA; O'Brien MJ; Cerda SR; Farraye FA; Stucchi AF; Becker JM
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17420-5. PubMed ID: 21969570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.
    Burmeister AR; Johnson MB; Chauhan VS; Moerdyk-Schauwecker MJ; Young AD; Cooley ID; Martinez AN; Ramesh G; Philipp MT; Marriott I
    J Neuroinflammation; 2017 Dec; 14(1):245. PubMed ID: 29237453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine.
    Renzi D; Pellegrini B; Tonelli F; Surrenti C; Calabrò A
    Am J Pathol; 2000 Nov; 157(5):1511-22. PubMed ID: 11073811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
    Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
    J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model.
    de la Puente-Redondo V; Tingley FD; Schneider RP; Hickman MA
    J Vet Pharmacol Ther; 2007 Aug; 30(4):281-7. PubMed ID: 17610400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours.
    González Moles MA; Mosqueda-Taylor A; Esteban F; Gil-Montoya JA; Díaz-Franco MA; Delgado M; Muñoz M
    Oral Oncol; 2008 Dec; 44(12):1127-33. PubMed ID: 18486533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells.
    Goode T; O'Connell J; Ho WZ; O'Sullivan GC; Collins JK; Douglas SD; Shanahan F
    Clin Diagn Lab Immunol; 2000 May; 7(3):371-6. PubMed ID: 10799448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.